99 related articles for article (PubMed ID: 18625756)
1. The ethics of randomized clinical trials in pulmonary arterial hypertension.
Halpern SD; Doyle R; Kawut SM
Proc Am Thorac Soc; 2008 Jul; 5(5):631-5. PubMed ID: 18625756
[TBL] [Abstract][Full Text] [Related]
2. Motivations of patients with pulmonary arterial hypertension to participate in randomized clinical trials.
Carroll R; Antigua J; Taichman D; Palevsky H; Forfia P; Kawut S; Halpern SD
Clin Trials; 2012 Jun; 9(3):348-57. PubMed ID: 22388077
[TBL] [Abstract][Full Text] [Related]
3. Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials.
Savarese G; Paolillo S; Costanzo P; D'Amore C; Cecere M; Losco T; Musella F; Gargiulo P; Marciano C; Perrone-Filardi P
J Am Coll Cardiol; 2012 Sep; 60(13):1192-201. PubMed ID: 22995024
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.
Galiè N; Seeger W; Naeije R; Simonneau G; Rubin LJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):81S-88S. PubMed ID: 15194183
[TBL] [Abstract][Full Text] [Related]
5. Using routine data to complement and enhance the results of randomised controlled trials.
Lewsey JD; Leyland AH; Murray GD; Boddy FA
Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
[TBL] [Abstract][Full Text] [Related]
6. A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials.
Miller FG; Brody H
Hastings Cent Rep; 2003; 33(3):19-28. PubMed ID: 12854452
[TBL] [Abstract][Full Text] [Related]
7. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective.
Gomberg-Maitland M; Dufton C; Oudiz RJ; Benza RL
J Am Coll Cardiol; 2011 Mar; 57(9):1053-61. PubMed ID: 21349396
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis].
Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963
[TBL] [Abstract][Full Text] [Related]
9. Clinical equipoise and the incoherence of research ethics.
Miller FG; Brody H
J Med Philos; 2007; 32(2):151-65. PubMed ID: 17454420
[TBL] [Abstract][Full Text] [Related]
10. Methodological quality and reporting of ethical requirements in phase III cancer trials.
Tuech JJ; Pessaux P; Moutel G; Thoma V; Schraub S; Herve C
J Med Ethics; 2005 May; 31(5):251-5. PubMed ID: 15863678
[TBL] [Abstract][Full Text] [Related]
11. Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity.
Colagiuri B
Clin Trials; 2010 Jun; 7(3):246-55. PubMed ID: 20421243
[TBL] [Abstract][Full Text] [Related]
12. Ethical issues of placebo-controlled studies in depression and a randomized withdrawal trial in Japan: case study in the ethics of mental health research.
Tashiro S; Yamada MM; Matsui K
J Nerv Ment Dis; 2012 Mar; 200(3):255-9. PubMed ID: 22373766
[TBL] [Abstract][Full Text] [Related]
13. [Female gender and pulmonary arterial hypertension: a complex relationship].
Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
[TBL] [Abstract][Full Text] [Related]
14. [Treatment algorithm for pulmonary arterial hypertension].
Hoeper MM
Herz; 2005 Jun; 30(4):326-31. PubMed ID: 15965810
[TBL] [Abstract][Full Text] [Related]
15. Are claims of advertisements in medical journals supported by RCTs?
Heimans L; van Hylckama Vlieg A; Dekker FW
Neth J Med; 2010 Jan; 68(1):46-9. PubMed ID: 20103825
[TBL] [Abstract][Full Text] [Related]
16. Ethical issues in psychiatric research on children and adolescents.
Hoop JG; Smyth AC; Roberts LW
Child Adolesc Psychiatr Clin N Am; 2008 Jan; 17(1):127-48, x. PubMed ID: 18036483
[TBL] [Abstract][Full Text] [Related]
17. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
[TBL] [Abstract][Full Text] [Related]
18. End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?
Peacock AJ; Naeije R; Galiè N; Rubin L
Eur Respir J; 2009 Jul; 34(1):231-42. PubMed ID: 19567606
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension: challenges in translational research and a vision for change.
Sutendra G; Michelakis ED
Sci Transl Med; 2013 Oct; 5(208):208sr5. PubMed ID: 24154604
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
